July 10, 2026
 

Researchers are studying medications that are FDA-approved for other conditions or have demonstrated safety in previous clinical use. These studies are designed to determine whether these treatments may also help reduce agitation symptoms and improve overall well-being in individuals with Alzheimer’s disease.

Read More



July 10, 2026
 

Researchers are studying medications that are FDA-approved for other conditions or have demonstrated safety in previous clinical use. These studies are designed to determine whether these treatments may also help reduce psychosis symptoms and improve overall well-being in individuals with Alzheimer’s.

Read More



January 9, 2026
 

Exploring how smart devices can help monitor daily activity and support individuals with early/prodromal Dementia with Lewy Body or mild cognitive impairment who have been diagnosed with REM sleep behavior disorder.

Read More



September 30, 2025
 

Alzheimer’s symptoms such as depression, anxiety, irritability and lack of motivation can significantly impact quality of life. A new research study is investigating an innovative approach to address these affective symptoms — using a portable, noninvasive brain stimulation device from the comfort of home.

Read More


image of three people sitting together outside setting
March 18, 2025
 

Families with multiple members diagnosed with Alzheimer’s disease or related dementias are invited to join a national study focused on understanding the genetic risks associated with these conditions. Participation will provide invaluable insights that could significantly advance this crucial research.

Read More



October 25, 2024
 

Although nearly all people with Down syndrome have high levels of this brain pathology similar to Alzheimer’s, and their associated brain changes appear by the early age of 40, this population continues to be underserved when it comes to Alzheimer’s research.

Read More